Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| NEJM: Pioglitazone lowers (by 72%) the risk of progression of impaired glucose tolerance to type 2 diabetes |
 |
 |
| NEJM: Conclusions. As compared with placebo, pioglitazone reduced the risk of conversion of impaired glucose tolerance to type 2 diabetes mellitus by 72% but was associated with significant weight gain and edema. |
